Opinion

Video

Graft-Versus-Host Disease: Pathogenesis, Clinical Challenges, and Unmet Treatment Needs

Author(s):

Hannah Choe, MD

In this video, Dr. Hannah Choe provides an overview of the background of graft-versus-host disease (GVHD), discusses currently approved treatments and their limitations, and the significant unmet treatment needs in GVHD.

Related Videos
Grzegorz S. Nowakowski, MD
John Seymour, MBBS, FRACP, PhD
3 KOLs are featured in this series.
3 KOLs are featured in this series.
Reid Merryman, MD
Partow Kebriaei, MD
Jean L. Koff, MD, MS
Sonali M. Smith, MD
Related Content
William G. Wierda, MD, PhD
September 6th 2024

Liso-Cel Elicits Consistent Responses in R/R CLL/SLL, Irrespective of High-Risk Features

OncLive On Air
March 18th 2024

Revisit the OncLive On Air Episodes From February 2024

Leonard Mazur, CEO, Citius Pharma, Citius Oncology
September 6th 2024

NCCN Adds Denileukin Diftitox to CTCL Clinical Practice Guidelines in Oncology

Alice Mims, MD, medical oncologist, associate professor, the Division of Hematology, The Ohio State University Comprehensive Cancer Center—James
February 26th 2024

Mims Expands on the Evaluation of Emavusertib in the TakeAim Leukemia Trial of AML and MDS

Reid W. Merryman, MD
September 5th 2024

Novel Cell-Free DNA Assays Expand the Reach of MRD Detection in Lymphoma

Rayne Helen Rouce, MD, BS, Baylor College of Medicine
September 4th 2024

Tisagenlecleucel Climbs into Earlier Lines of Therapy for Pediatric R/R B-ALL